Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma-Reference-Cited by-同舟云学术

Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma

Published:2016-10-09 Issue:4 Volume:8 Page:7050-7058
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Luo Jizhuang¹,Wang Rui¹,Han Baohui²,Zhang Jie³,Zhao Heng¹,Fang Wentao¹,Luo Qingquan⁴,Yang Jun¹,Yang Yunhai¹,Zhu Lei³,Chen Tianxiang¹,Cheng Xinghua⁵,Huang Qingyuan¹,Wang Yiyang¹,Zheng Jiajie¹,Chen Haiquan¹⁵⁶⁷

Affiliation:

1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

2. Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

3. Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

4. Department of Shanghai Lung Tumor Clinic Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

5. Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

6. Institutes of Biomedical Sciences, Fudan University, Shanghai, China

7. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma;Nature Communications;2023-11-08

2. Safety and local efficacy of computed tomography-guided microwave ablation for treating early-stage non-small cell lung cancer adjacent to bronchovascular bundles;European Radiology;2023-07-28

3. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma;2022-11-15

4. SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients;European Radiology;2022-02-08

5. Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy;Cancers;2022-01-29